A case of Trousseau syndrome: Screening, detection and complication
Open Life Sciences · 08.02.2024 · 19 (1)
DOI: 10.1515/biol-2022-0824 ↗Kurz gefasst
Fallbericht in der Zeitschrift Open Life Sciences, online erschienen am 08.02.2024. Verfasst von Hui Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Binzhou Medical University Hospital, Binzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Trousseau syndrome (TS) is a malignant tumor-mediated complication of the hypercoagulable state with an unknown etiology. Laboratory testing results in patients with TS have indicated elevated D-dimer levels. The imaging analysis in patients who had undergone stroke has shown the presence of several cerebral infarction lesions in multiple regions. Since patients have had malignant tumors for a long time when they suffer from a secondary stroke, the optimum time for radical tumor treatment is usually missed. This study reports a case to improve the early screening and detection of TS and reduce the risk of recurrence of cerebral infarction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Binzhou Medical University Hospital, Binzhou, China.
- Binzhou Medical University, Binzhou, China.
Zitieren
APA
Liu, H., Jiang, M., Wu, N., Liu, Q., & Fan, X. (2024). A case of Trousseau syndrome: Screening, detection and complication. Open Life Sciences, 19(1). https://doi.org/10.1515/biol-2022-0824
Vancouver
Liu H, Jiang M, Wu N, Liu Q, Fan X. A case of Trousseau syndrome: Screening, detection and complication. Open Life Sciences. 2024;19(1). doi:10.1515/biol-2022-0824
BibTeX
@article{Liu2024,
author = {Liu, Hui and Jiang, Meng and Wu, Nan and Liu, Qingxin and Fan, Xueli},
title = {A case of Trousseau syndrome: Screening, detection and complication},
journal = {Open Life Sciences},
year = {2024},
volume = {19},
number = {1},
doi = {10.1515/biol-2022-0824}
}
EUVIMED